홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-(3-amino-oxetan-3-yl)-N-methyl-acetamide → 5-(3,3-difluoroazetidin-1-yl)-N-[3-[2-(methylamino)-2-oxoethyl]oxetan-3-yl]-4-(2,2,2-trifluoroethoxy)pyridine-2-carboxamide

HRID 1480299
인쇄

반응식

HRID 1480299 반응식
[F:1][C:2]1([F:21])[CH2:5][N:4]([C:6]2[C:7]([O:15][CH2:16][C:17]([F:20])([F:19])[F:18])=[CH:8][C:9]([C:12](O)=[O:13])=[N:10][CH:11]=2)[CH2:3]1.[NH2:22][C:23]1([CH2:27][C:28]([NH:30][CH3:31])=[O:29])[CH2:26][O:25][CH2:24]1>>[F:21][C:2]1([F:1])[CH2:3][N:4]([C:6]2[C:7]([O:15][CH2:16][C:17]([F:18])([F:19])[F:20])=[CH:8][C:9]([C:12]([NH:22][C:23]3([CH2:27][C:28]([NH:30][CH3:31])=[O:29])[CH2:26][O:25][CH2:24]3)=[O:13])=[N:10][CH:11]=2)[CH2:5]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 841070862-(3-amino-oxetan-3-yl)-N-methyl-acetamideHCID 902040455-(3,3-Difluoroazetidin-1-yl)-4-(2,2,2-trifluoroethoxy)picolinic acid

생성물 1

HCID 902032815-(3,3-difluoroazetidin-1-yl)-N-[3-[2-(methylamino)-2-oxoethyl]oxetan-3-yl]-4-(2,2,2-trifluoroethoxy)pyridine-2-carboxamide

실험 절차

The title compound was synthesized in analogy to Example 112e, using 5-(3,3-difluoroazetidin-1-yl)-4-(2,2,2-trifluoroethoxy)pyridine-2-carboxylic acid (Example 223b) and 2-(3-aminooxetan-3-yl)-N-methyl-acetamide (example 231a) as starting materials and isolated (25 mg, 43%); MS (ESI, m/z): 439.5 (M+H+).

후처리

  1. customisolated (25 mg, 43%)

출처 및 근거

ORD 기록
ord-9fa5914a37124348872ad495df0ba254
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09409866B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트